Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus

In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis B virus, there was no significant effect of maternal TDF use on maternal or infant bone mineral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Salvadori, Nicolas, Fan, Bo, Teeyasoontranon, Waralee, Ngo-Giang-Huong, Nicole, Phanomcheong, Siriluk, Luvira, Anita, Puangsombat, Achara, Suwannarat, Arunrat, Srirompotong, Ussanee, Putiyanun, Chaiwat, Cressey, Tim R, Decker, Luc, Khamduang, Woottichai, Harrison, Linda, Tierney, Camlin, Shepherd, John A, Kourtis, Athena P, Bulterys, Marc, Siberry, George K, Jourdain, Gonzague
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6579954/
https://ncbi.nlm.nih.gov/pubmed/30924492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy982
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados